BeiGene, Ltd. (ONC) Tops Q4 EPS by 77c, provides guidance

Go back to BeiGene, Ltd. (ONC) Tops Q4 EPS by 77c, provides guidance

JPMorgan Reiterates Overweight Rating on BeiGene Ltd. (ONC), PT $311

March 3, 2025 4:19 PM EST

JPMorgan analyst Jessica Fye reiterated an Overweight rating and $311.00 price target on BeiGene Ltd. (NASDAQ: ONC)

The analyst comments "We hosted a call with mgmt and investors following ONCs strong 4Q print and 2025 guide. The conversation touched on the various factors associated with 2025... More

BeiGene Ltd. (ONC) PT Raised to $308 at Jefferies

February 27, 2025 3:36 PM EST

Jefferies analyst Kelly Shi raised the price target on BeiGene Ltd. (NASDAQ: ONC) to $308.00 (from $286.00) while maintaining a Buy rating.

The analyst comments "ONC posted strong FY results, with $3.8B FY rev (+55% YoY, vs $3.7B cons). Despite investor discussion of script discrepancies, Brukinsa... More